PharmaTher's Sairiyo Therapeutics Gets OK to Initiate a Phase 1 Human Clinical Trial of PD-001 (Reformulated Cepharanthine)

MT NewswiresAug 19 08:04 ET

Express News | Pharmather Holdings Ltd - Generic Drug User Fee Amendments of 2022 Goal Date of October 29, 2024

ReutersMay 10 08:00 ET

Express News | Pharmather Holdings Ltd - Receipt of Amendment Acknowledgment Letter for Its Priority Original Abbreviated New Drug Application for Ketamine

ReutersMay 10 07:59 ET

Express News | Pharmather Holdings Ltd - Receipt of a Complete Response Letter ("Crl") for Its Priority Original Abbreviated New Drug Application for Ketamine

Moomoo 24/7Apr 18 16:00 ET

Express News | Pharmather Holdings Ltd: Has Completed Necessary Tests and Responses to Address Fda's Comments

Moomoo 24/7Apr 18 16:00 ET

PharmaTher Updated on Its Priority Original Abbreviated New Drug Application for Ketamine

MT NewswiresApr 16 08:39 ET